spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare Industry NewsFeed

 HSMN NewsFeed - 19 Oct 2021
Accuray Unveils VOLO(TM) Ultra, the Latest Innovation for the Radixact(R) System, at ASTRO 2021
Devices Oncology
 HSMN NewsFeed - 18 Oct 2021
FDA Approves Cyltezo, the First Interchangeable Biosimilar to Humira
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 18 Oct 2021
NeuExcell Therapeutics names Lori Gavrin as Chief Business and Strategy Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Oct 2021
Oyster Point Pharma Announces FDA Approval of TYRVAYA(TM) (varenicline solution) Nasal Spray for the Treatment of the Signs and Symptoms of Dry Eye Disease
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 15 Oct 2021
SpinaFX Medical announces John Soloninka as Chief Operating Officer
Devices Neurosurgery Orthopaedic Personnel
 HSMN NewsFeed - 15 Oct 2021
Aspaveli(R) (pegcetacoplan) receives positive CHMP opinion for treatment of PNH
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 14 Oct 2021
NuVasive Launches Latest Porous PEEK Implant for Posterior Spine Surgery
Devices Neurosurgery Orthopaedic Product Launch
 HSMN NewsFeed - 14 Oct 2021
Immunic, Inc. Appoints Patrick Walsh as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Oct 2021
Varian Receives FDA "Breakthrough Device Designation" For Embozene(R) Microspheres For Genicular Artery Embolization For Symptomatic Knee Osteoarthritis
Devices Interventional FDA
 HSMN NewsFeed - 13 Oct 2021
Poseida Therapeutics Announces Leadership Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Oct 2021
Laborie Medical Technologies Acquires Pelvalon
Devices Mergers & Acquisitions
 HSMN NewsFeed - 13 Oct 2021
FDA Approves Verzenio(R) (abemaciclib) as the First and Only CDK4/6 Inhibitor for Certain People with HR+ HER2- High Risk Early Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Oct 2021
Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Oct 2021
Andreas Tsukada Joins Caris Life Sciences as President of Japanese Operations and Head of International
Diagnostics Personnel
 HSMN NewsFeed - 11 Oct 2021
Sirtex Medical and China Grand Pharmaceutical announce successful first administration of SIR-Spheres(R) Y-90 resin microspheres in China
Devices Oncology
 HSMN NewsFeed - 11 Oct 2021
Medtronic Hugo(TM) Robotic-Assisted Surgery System Receives European CE Mark Approval
Devices Surgery Regulatory
 HSMN NewsFeed - 8 Oct 2021
18-Month Below-the-Knee Data with MedAlliance's SELUTION SLR(TM) Presented as Late Breaking Trial at VIVA
Devices Interventional
 HSMN NewsFeed - 8 Oct 2021
Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM
Devices Oncology FDA
 HSMN NewsFeed - 7 Oct 2021
Venclose MAVEN Earns FDA Clearance to Treat Incompetent Perforator Veins
Devices Interventional FDA
 HSMN NewsFeed - 7 Oct 2021
AffyImmune Therapeutics Announces $30M Series A+ Financing from ORI Capital
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Oct 2021
Tris Pharma(R) Hires Seasoned Business Development Executive
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 7 Oct 2021
Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases
Biopharmaceuticals Neurology
 HSMN NewsFeed - 7 Oct 2021
SAGA Diagnostics appoints Peter Collins as Chief Executive Officer
Diagnostics Personnel
 HSMN NewsFeed - 6 Oct 2021
U.S. FDA Accepts COUR Pharmaceuticals Investigational New Drug Application (IND) for a Proof-of-Concept Study for the Treatment of Primary Biliary Cholangitis (PBC)
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Oct 2021
Boston Scientific Announces Agreement to Acquire Baylis Medical Company Inc.
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 6 Oct 2021
BD Announces 510(k) Clearance of Expanded Indications for the Rotarex(TM) Atherectomy System
Devices Interventional FDA
More stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!